6,678 trials
HIV Dementia
Primary: Change in Monocyte Surface Markers Expression (Expressed as Percentage), Following Treatment of Chronic HIV+/ HAART+ Subjects With Atorvastatin (T=12wks Versus T=0wk)…
Fracture of Shoulder and Upper Arm
Primary: Quality of Analgesia — 2.1; 2.6; 4.1; 4.0 score on a scale
Urge Incontinence · Urinary Incontinence, Urge
Primary: The Number of Participants Who Completed and Discontinued the Study — 11; 10; 1; 1 Participants — p=0.949
Intrinsic Aging of Skin
Primary: Number of Genes Upregulated or Downregulated as Assessed by RNA Sequencing (Older Group, Retinol Versus Placebo) — 23; 21 genes
Primary Hyperparathyroidism · Vitamin D Deficiency
Primary: Serum Parathyroid Hormone (PTH) Level
Pancreatectomy
Primary: Overall Pain in Postoperative Period — 1.6; 2.7 score on a scale — p=0.1459
Postoperative Pain
Primary: Visual Aanalog Scale (VAS) for Pain Assessment With Cough at 48 Hours — 1.7; 3.9 units on a scale — p=.0022
Non-Cystic Fibrosis Bronchiectasis
Primary: Bacterial Clearance Rate of Sputum — 38; 16 Participants
Bipolar Disorder
Primary: Change in Serum Brain Derived Neurotrophic Factor (BDNF) — 23.1; 90.7 pg/ml
Memory Impairment Due to Corticosteroid Use · Hypomania Due to Corticosteroid Use · Hippocampal Atrophy Due to Corticosteroid
Primary: Rey Auditory Verbal Learning Test (RAVLT) — 46.1; 40.1 T-scores
Pain, Postoperative
Primary: Comparing Pain Intensity and Opioid-Related Adverse Effects Using Overall Benefit of Analgesia Score (OBAS). — 2; 0; 3 score on a scale — p=0.542
Chronic Obstructive Pulmonary Disease and Allied Conditions
Primary: Change From Baseline in Carotid Femoral-Pulse Wave Velocity at Month 6 — 1.07; 0.99 meters per second (m/s)
Neuromuscular Blockade
Primary: Operating Room (OR) Turnover Time When Using Sugammadex Instead of Combination of Neostigmine and Glycopyrrolate. — 49.7; 49.45 Minutes
Type 2 Diabetes Mellitus (T2DM)
Primary: Number of Patients With Clinically Significant Weight Reduction (>5%) Compared to Baseline at Month 12 — 50; 4; 50; 26 Participants
Depression
Primary: Response as Assessed by Participants' Change in Depression Rating — 17; 11; 1; 9 Participants